Agenus, Inc. (AGEN)
2.96
+0.11
(+3.86%)
USD |
NASDAQ |
Feb 13, 14:15
Agenus Free Cash Flow : -89.31M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cardiff Oncology, Inc. | -42.27M |
| Curis, Inc. | -30.09M |
| LadRx Corp. | -- |
| Plus Therapeutics, Inc. | -15.78M |
| Windtree Therapeutics, Inc. | -15.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -14.74M |
| Cash from Investing (Quarterly) | 0.076M |
| Cash from Financing (Quarterly) | 6.683M |
| Free Cash Flow Per Share (Quarterly) | -0.4485 |
| Free Cash Flow to Equity (Quarterly) | 47.08M |
| Free Cash Flow to Firm (Quarterly) | -1.493M |
| Free Cash Flow Yield | -111.8% |